Quetiapine and Wolff-Parkinson-White Syndrome
Michael Chen1, Hassaan Gomaa2, Alonso Cortez-Resendiz2
1Department of Psychiatry, Lehigh Valley Health Network, 2545 Schoenersville road, Bethlehem PA 18017, USA.
Abstract:
Quetiapine is occasionally associated with cardiovascular adverse effects such as QTc prolongation. QTc prolongation is a side effect that requires monitoring in order to avoid more serious cardiac complications. One particular understudied area is the potential for antipsychotics to elicit electroconduction abnormalities in patients with Wolff-Parkinson-White (WPW) Syndrome. In the present report, we describe a case of quetiapine overdose in a patient with WPW.
More Related Videos
10:25Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Antipsychotic Drugs: Typical and Atypical Agents
